|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansen RM: Systemic therapy of colorectal
cancer. Wis Med J. 87:27–29. 1988.PubMed/NCBI
|
|
3
|
Moriarity A, O'Sullivan J, Kennedy J,
Mehigan B and McCormick P: Current targeted therapies in the
treatment of advanced colorectal cancer: A review. Ther Adv Med
Oncol. 8:276–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yates L, Norbury C and Gilbert RC: The
long and short of MicroRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rasnic R, Linial N and Linial M: Enhancing
identification of cancer types via lowly-expressed microRNAs.
Nucleic Acids Res. 45:5048–5060. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma Y, Zhang P, Wang F, Zhang H, Yang Y,
Shi C, Xia Y, Peng J, Liu W, Yang Z and Qin H: Elevated oncofoetal
miR-17-5p expression regulates colorectal cancer progression by
repressing its target gene P130. Nat Commun. 3:12912012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asangani IA, Rasheed SA, Nikolova DA,
Leupold JH, Colburn NH, Post S and Allgayer H: MicroRNA-21 (miR-21)
post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal
cancer. Oncogene. 27:2128–2136. 2008. View Article : Google Scholar
|
|
9
|
Imaoka H, Toiyama Y, Fujikawa H, Hiro J,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, et al:
Circulating microRNA-1290 as a novel diagnostic and prognostic
biomarker in human colorectal cancer. Ann Oncol. 27:1879–1886.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ng L, Wan TM, Man JH, Chow AK, Iyer D,
Chen G, Yau TC, Lo OS, Foo DC, Poon JT, et al: Identification of
serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Oncotarget. 8:27393–27400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Slattery ML, Herrick JS, Pellatt DF,
Stevens JR, Mullany LE, Wolff E, Hoffman MD, Samowitz WS and Wolff
RK: MicroRNA profiles in colorectal carcinomas, adenomas and normal
colonic mucosa: Variations in miRNA expression and disease
progression. Carcinogenesis. 37:245–261. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang G, Li J, Sun B, Li S, Lü L, Wang Y,
Chen B and Xiao Z: Deep sequencing reveals complex mechanisms of
microRNA deregulation in colorectal cancer. Int J Oncol.
45:603–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Guan S, Chen X, Liu B, Liu F, Han
L, Un Nesa E, Song Q, Bao C, Wang X and Cheng Y: Clinical potential
of miR-3651 as a novel prognostic biomarker for esophageal squamous
cell cancer. Biochem Biophys Res Commun. 465:30–34. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ries J, Vairaktaris E, Agaimy A, Kintopp
R, Baran C, Neukam FW and Nkenke E: miR-186, miR-3651 and miR-494:
Potential biomarkers for oral squamous cell carcinoma extracted
from whole blood. Oncol Rep. 31:1429–1436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lindsay EA, Vitelli F, Su H, Morishima M,
Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler
PJ, et al: Tbx1 haploinsufficieny in the DiGeorge syndrome region
causes aortic arch defects in mice. Nature. 410:97–101. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen L, Fulcoli FG, Tang S and Baldini A:
Tbx1 regulates proliferation and differentiation of multipotent
heart progenitors. Circ Res. 105:842–851. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu H, Viola A, Zhang Z, Gerken CP,
Lindsay-Illingworth EA and Baldini A: Tbx1 regulates population,
proliferation and cell fate determination of otic epithelial cells.
Dev Biol. 302:670–682. 2007. View Article : Google Scholar :
|
|
18
|
Botchkarev VA and Fessing MY: Edar
signaling in the control of hair follicle development. J Investig
Dermatol Symp Proc. 10:247–251. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ryan AK, Goodship JA, Wilson DI, Philip N,
Levy A, Seidel H, Schuffenhauer S, Oechsler H, Belohradsky B,
Prieur M, et al: Spectrum of clinical features associated with
interstitial chromosome 22q11 deletions: A European collaborative
study. J Med Genet. 34:798–804. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang N, Li Y, Wei J, Pu J, Liu R, Yang Q,
Guan H, Shi B, Hou P and Ji M: TBX1 functions as a tumor suppressor
in thyroid cancer through inhibiting the activities of the PI3K/AKT
and MAPK/ERK pathways. Thyroid. 29:378–394. 2019. View Article : Google Scholar
|
|
21
|
Sun H and Jiang P: MicroRNA-451a acts as
tumor suppressor in cutaneous basal cell carcinoma. Mol Genet
Genomic Med. 6:1001–1009. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hari DM, Leung AM, Lee JH, Sim MS, Vuong
B, Chiu CG and Bilchik AJ: AJCC cancer staging manual 7th edition
criteria for colon cancer: Do the complex modifications. J Am Coll
Surg. 217:181–190. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu C, Chen X, Wang Q, Xu X and Xu B: TNFα
promotes glio-blastoma A172 cell mitochondrial apoptosis via
augmenting mitochondrial fission and repression of MAPK-ERK-YAP
signaling pathways. Onco Targets Ther. 11:7213–7227. 2018.
View Article : Google Scholar :
|
|
25
|
Baldini A, Fulcoli FG and Illingworth E:
Tbx1: Transcriptional and developmental functions. Curr Top Dev
Biol. 122:223–243. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Moridikia A, Mirzaei H, Sahebkar A and
Salimian J: MicroRNAs: Potential candidates for diagnosis and
treatment of colorectal cancer. J Cell Physiol. 233:901–913. 2018.
View Article : Google Scholar
|
|
28
|
Amankwatia EB, Chakravarty P, Carey FA,
Weidlich S, Steele RJ, Munro AJ, Wolf CR and Smith G: MicroRNA-224
is associated with colorectal cancer progression and response to
5-fluorouracil-based chemotherapy by KRAS-dependent and
-independent mechanisms. Br J Cancer. 112:1480–1490. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li S, Wu X, Xu Y, Wu S, Li Z, Chen R,
Huang N, Zhu Z and Xu X: miR-145 suppresses colorectal cancer cell
migration and invasion by targeting an ETS-related gene. Oncol Rep.
36:1917–1926. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu HR, Huang RZ, Yu XN, Shi X,
Bilegsaikhan E, Guo HY, Song GQ, Weng SQ, Dong L, Janssen HLA, et
al: Microarray expression profiling of microRNAs reveals potential
biomarkers for hepatocellular carcinoma. Tohoku J Exp Med.
245:89–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Della Vittoria Scarpati G, Calura E, Di
Marino M, Romualdi C, Beltrame L, Malapelle U, Troncone G, De
Stefano A, Pepe S, De Placido S, et al: Analysis of differential
miRNA expression in primary tumor and stroma of colorectal cancer
patients. Biomed Res Int. 2014:8409212014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Burotto M, Chiou VL, Lee JM and Kohn EC:
The MAPK pathway across different malignancies: A new perspective.
Cancer. 120:3446–3456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Araujo WM, Robbs BK, Bastos LG, de
Souza WF, Vidal FC, Viola JP and Morgado-Diaz JA: PTEN
overexpression cooperates with lithium to reduce the malignancy and
to increase cell death by apoptosis via PI3K/AKT suppression in
colorectal cancer cells. J Cell Biochem. 117:458–469. 2016.
View Article : Google Scholar
|
|
35
|
Tian XQ, Guo FF, Sun DF, Wang YC, Yang L,
Chen SL, Hong J and Fang JY: Downregulation of ZNF278 arrests the
cell cycle and decreases the proliferation of colorectal cancer
cells via inhibition of the ERK/MAPK pathway. Oncol Rep.
38:3685–3692. 2017.PubMed/NCBI
|
|
36
|
Zhou Q, Chen J, Feng J, Xu Y, Zheng W and
Wang J: SOSTDC1 inhibits follicular thyroid cancer cell
proliferation, migration, and EMT via suppressing PI3K/Akt and
MAPK/Erk signaling pathways. Mol Cell Biochem. 435:87–95. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Vakana E, Pratt S, Blosser W, Dowless M,
Simpson N, Yuan XJ, Jaken S, Manro J, Stephens J, Zhang Y, et al:
LY3009120, a panRAF inhibitor, has significant anti-tumor activity
in BRAF and KRAS mutant preclinical models of colorectal cancer.
Oncotarget. 8:9251–9266. 2017. View Article : Google Scholar :
|
|
38
|
Soo HC, Chung FF, Lim KH, Yap VA, Bradshaw
TD, Hii LW, Tan SH, See SJ, Tan YF, Leong CO and Mai CW:
Cudraflavone C induces tumor-specific apoptosis in colorectal
cancer cells through inhibition of the phosphoinositide 3-kinase
(PI3K)-AKT pathway. PLoS One. 12:e01705512017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Trempus CS, Wei SJ, Humble MM, Dang H,
Bortner CD, Sifre MI, Kissling GE, Sunman JA, Akiyama SK, Roberts
JD, et al: A novel role for the T-box transcription factor Tbx1 as
a negative regulator of tumor cell growth in mice. Mol Carcinog.
50:981–991. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang J, Bai Y, Li H, Greene SB, Klysik E,
Yu W, Schwartz RJ, Williams TJ and Martin JF: MicroRNA-17-92, a
direct Ap-2α transcriptional target, modulates T-box factor
activity in orofacial clefting. PLoS Genet. 9:e10037852013.
View Article : Google Scholar
|
|
41
|
Wang XR, Zhang XM, Du J and Jiang H:
MicroRNA-182 regulates otocyst-derived cell differentiation and
targets T-box1 gene. Hear Res. 286:55–63. 2012. View Article : Google Scholar : PubMed/NCBI
|
